These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31820304)

  • 41. Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study.
    Hide M; Yagami A; Togawa M; Saito A; Furue M
    Allergol Int; 2017 Apr; 66(2):317-325. PubMed ID: 27599913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bioequivalence Study of Two Orodispersible Rizatriptan Formulations of 10 mg in Healthy Volunteers.
    Cánovas M; Polonio F; Cabré F
    Sci Pharm; 2016 Jun; 84(3):514-522. PubMed ID: 28117317
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics, Safety, and Bioequivalence of Two Empagliflozin Formulations after Single Oral Administration under Fasting and Fed Conditions in Healthy Chinese Subjects: An Open-label Randomized Single-dose Two-sequence, Two-treatment, Two-period Crossover Study.
    Chen G; Zhang D; Du A; Zhang Y; Zhang Y; Zhang L; Zang S; Liu X; Wang Z; Zhen H; Liu Y; Yang S; Wang J
    Pharmacotherapy; 2020 Jul; 40(7):623-631. PubMed ID: 32498113
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bioequivalence studies of film-coated tablet and chewable tablet generic formulations of montelukast in healthy volunteers.
    Cánovas M; Arcabell M; Martínez G; Canals M; Cabré F
    Arzneimittelforschung; 2011; 61(11):610-6. PubMed ID: 22232849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A single-dose, randomized, two-way crossover study comparing two olanzapine tablet products in healthy adult male volunteers under fasting conditions.
    Elshafeey AH; Elsherbiny MA; Fathallah MM
    Clin Ther; 2009 Mar; 31(3):600-8. PubMed ID: 19393850
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers.
    Iqbal M; Khuroo A; Batolar LS; Tandon M; Monif T; Sharma PL
    Clin Ther; 2010 Mar; 32(3):588-96. PubMed ID: 20399995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bioequivalence study of a new sildenafil 100 mg orodispersible film compared to the conventional film-coated 100 mg tablet administered to healthy male volunteers.
    Radicioni M; Castiglioni C; Giori A; Cupone I; Frangione V; Rovati S
    Drug Des Devel Ther; 2017; 11():1183-1192. PubMed ID: 28442892
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized, single-dose, two-sequence, two-period, crossover study to assess the bioequivalence between two formulations of clonazepam tablet in healthy subjects.
    Davanço MG; Meulman J; Guzmán MRP; Palomino DMH; Tuiran CMG; Duarte FG; de Campos DR
    Drug Dev Ind Pharm; 2019 Dec; 45(12):1982-1987. PubMed ID: 31702402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metronidazole immediate release formulations: a fasting randomized open-label crossover bioequivalence study in healthy volunteers.
    de Freitas Silva M; Schramm SG; Kano EK; Koono EE; Manfio JL; Porta V; dos Reis Serra CH
    Arzneimittelforschung; 2012 Oct; 62(10):490-5. PubMed ID: 22918856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of pharmacokinetics of two fenofibrate tablet formulations in healthy human subjects.
    Chachad SS; Gole M; Malhotra G; Naidu R
    Clin Ther; 2014 Jun; 36(6):967-73. PubMed ID: 24844853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases.
    Yagami A; Furue M; Togawa M; Saito A; Hide M
    J Dermatol; 2017 Apr; 44(4):375-385. PubMed ID: 27862227
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.
    Galan-Herrera JF; Poo JL; Rosales-Sanchez O; Fuentes-Fuentes E; Cariño L; Burke-Fraga V; Namur S; Parra MG
    Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single dose bioequivalence study of alpha-methyldopa tablet formulations using a modified HPLC method.
    Valizadeh H; Nemati M; Hallaj-Nezhadi S; Ansarin M; Zakeri-Milani P
    Arzneimittelforschung; 2010; 60(10):607-11. PubMed ID: 21125810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bioequivalence of two tablet formulations of clopidogrel in healthy Argentinian volunteers: a single-dose, randomized-sequence, open-label crossover study.
    Di Girolamo G; Czerniuk P; Bertuola R; Keller GA
    Clin Ther; 2010 Jan; 32(1):161-70. PubMed ID: 20171421
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics and Bioequivalence of Single-Oral-Dose Linagliptin: A Randomized, 2-Period Crossover Trial in Chinese Healthy Subjects Under Fasting and Fed Conditions.
    Li Y; Zhang X; Qi L; Tong Y; Bai H; Liu J; Liu Y; Chen Y; Wang X
    Clin Pharmacol Drug Dev; 2022 Oct; 11(10):1157-1164. PubMed ID: 35514254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Male Volunteers: A Randomized, Single-Dose, Two-Period, Two-Sequence Crossover Study.
    Chen J; Zhuang J; Wu J; Chen X; Wang X; Huang L; Zeng G; Chen J; Liao X; Chen X; Ma Z; Zhong G; Huang M; Zhong D; Zhao X
    Clin Pharmacol Drug Dev; 2019 Feb; 8(2):217-222. PubMed ID: 29659187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the effects of formulation, food, or a proton-pump inhibitor on the pharmacokinetics of glasdegib (PF-04449913) in healthy volunteers: a randomized phase I study.
    Shaik N; Hee B; Wei H; LaBadie RR
    Cancer Chemother Pharmacol; 2019 Mar; 83(3):463-472. PubMed ID: 30536154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation.
    Ochoa D; Román M; Belmonte C; Martín-Vilchez S; Mejía-Abril G; Abad-Santos F; Hernández G; Arranz P; Elgezabal L; Fernández N
    Adv Ther; 2021 Jul; 38(7):4070-4081. PubMed ID: 34125400
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioequivalence study of two formulations of memantine hydrochloride tablets in healthy male Chinese subjects under fasting and fed conditions.
    Zheng J; Chen J; Wu J; Yang M; Mai L; Yu X; Huang M; Zhong G
    Int J Clin Pharmacol Ther; 2020 Oct; 58(10):575-582. PubMed ID: 32729819
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.
    Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A
    Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.